Nexus Surgical & Medicare Fair Value
Nexus Surgical & Medicare fair value. Nexus Surgical & Medicare (NEXUSSURGL) average fair value is ₹16.96 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹32.95 (-48.52%), fair value range ₹3.33–₹34.48. Explore NEXUSSURGL fundamental worth to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
NEXUSSURGL Fair Value vs Current Price — Valuation Summary
NEXUSSURGL average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit Nexus Surgical & Medicare share price screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
NEXUSSURGL Fair Value Analysis — Data Sources & Coverage
Nexus Surgical & Medicare financial data sources, valuation methods applied and sector benchmarks used. Check NEXUSSURGL market cap trends to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
NEXUSSURGL vs Financial Services Sector Peers — P/E, P/B & Market Cap
Nexus Surgical & Medicare P/E ratio, P/B ratio and market capitalisation vs Financial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Ajcon Global Services | AJCON | 121.6 | 1.57 | ₹35 |
| Virat Leasing | VLL | -204.07 | 9.41 | ₹143 |
| Mrugesh Trading | MRUTR | - | 77.48 | ₹5,477 |
| Bajaj Holdings & Investm… | BAJAJHLDNG | 13.34 | 1.64 | ₹118,706 |
| Supra Trends | SUPRATRE | -28.11 | 1.75 | ₹35 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.